These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12116778)

  • 1. [Nuchal translucency in the fetus and congenital heart defects].
    Taipale PJ; Hiilesmaa V
    Duodecim; 2001; 117(5):513-5. PubMed ID: 12116778
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fetal nuchal translucency: possible involvement of early cardiac failure.
    Montenegro N; Matias A; Areias JC; Castedo S; Barros H
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):265-8. PubMed ID: 9383878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency and congenital heart defects: heart failure or not?
    Simpson JM; Sharland GK
    Ultrasound Obstet Gynecol; 2000 Jul; 16(1):30-6. PubMed ID: 11084962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased nuchal translucency and normal karyotype: coping with uncertainty.
    Bilardo CM
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):99-101. PubMed ID: 11251914
    [No Abstract]   [Full Text] [Related]  

  • 9. [Enlarged nuchal translucency with normal karyotype].
    Oueslati A; Amroussi A; Youssef A; Ben Ghezala M; Agrebi W; Ben Mefteh M; Oueslati H
    Tunis Med; 2008 Jun; 86(6):617-8. PubMed ID: 19216466
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuchal translucency and its relationship to congenital heart disease.
    Devine PC; Simpson LL
    Semin Perinatol; 2000 Oct; 24(5):343-51. PubMed ID: 11071375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuchal translucency in fetuses with a normal karyotype.
    Hyett JA
    Prenat Diagn; 2002 Oct; 22(10):864-8. PubMed ID: 12378566
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.
    Makrydimas G; Sotiriadis A; Ioannidis JP
    Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prenatal diagnosis of major congenital heart defects.
    Carvalho JS
    Curr Opin Obstet Gynecol; 2001 Apr; 13(2):155-9. PubMed ID: 11315870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Down's syndrome. Nuchal translucency screening may help detect congenital heart disease.
    Simpson JM
    BMJ; 2002 Jan; 324(7329):112. PubMed ID: 11808525
    [No Abstract]   [Full Text] [Related]  

  • 16. Search for hemodynamic compromise at 11-14 weeks in monochorionic twin pregnancy: is abnormal flow in the ductus venosus predictive of twin-twin transfusion syndrome?
    Matias A; Ramalho C; Montenegro N
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):79-86. PubMed ID: 16203591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study.
    Hiippala A; Eronen M; Taipale P; Salonen R; Hiilesmaa V
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):18-22. PubMed ID: 11489219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nuchal translucency and CATCH 22.
    Lazanakis MS; Rodgers K; Economides DL
    Prenat Diagn; 1998 May; 18(5):507-10. PubMed ID: 9621387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fetal echocardiography--normal ultrasound findings in the fetal heart].
    Markov D
    Akush Ginekol (Sofiia); 2007; 46(1):7-18. PubMed ID: 17469456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.